8-K: Pennant Group Reports Record 2025 Results, Strong Growth

The Pennant Group, Inc. announced record-breaking financial and operational results for the fourth quarter and full fiscal year 2025, driven by significant growth in both home health, hospice, and senior living segments.

Summary

• Full year 2025 GAAP diluted earnings per share was $0.84, with $0.24 for the fourth quarter.
• Adjusted diluted earnings per share for the full year was $1.18, and $0.34 for the fourth quarter.
• Total revenue for the full year reached $947.7 million, a 36.3% increase over the prior year, and $289.3 million for the fourth quarter, up 53.2%.
• Net income for the full year was $29.6 million, a 31.1% increase, and $8.6 million for the fourth quarter, up 50.0%.
• Consolidated Adjusted EBITDA for the full year was $72.5 million, increasing 36.0%, and $22.4 million for the fourth quarter, up 62.5%.
• Home Health and Hospice Services segment revenue grew 41.0% to $732.7 million for the full year and 64.3% to $233.3 million for the fourth quarter.
• Total home health admissions for the full year were 86,076, a 44.1% increase, and 28,941 for the fourth quarter, an 81.3% increase.
• Hospice average daily census for the full year was 4,204, up 28.6%, and 5,060 for the fourth quarter, up 46.9%.
• Senior Living Services segment revenue for the full year was $215.0 million, a 22.3% increase, and $56.1 million for the fourth quarter, up 19.6%.
• Senior Living average occupancy for the fourth quarter was 80.6%, an increase of 200 basis points over the prior year quarter.

Sentiment

Score: 9

Explanation: StockSavvy.ai views this as a highly positive report, reflecting strong financial performance, significant operational growth across all segments, and strategic expansion, all contributing to a robust outlook for 2026.

Positives

• Achieved record-breaking performance and growth across the company in 2025.
• Total revenue increased significantly by 36.3% for the full year and 53.2% for the fourth quarter.
• Net income saw substantial growth, up 31.1% for the full year and 50.0% for the fourth quarter.
• Adjusted diluted EPS increased to $1.18 for the full year and $0.34 for the fourth quarter, demonstrating improved profitability.
• Consolidated Adjusted EBITDA grew 36.0% for the full year and 62.5% for the fourth quarter.
• Home Health and Hospice Services segment revenue increased by 41.0% for the full year, driven by strong admission growth (total home health admissions up 44.1% and hospice average daily census up 28.6%).
• Senior Living Services segment revenue increased by 22.3% for the full year, with average occupancy up 200 basis points in the fourth quarter.
• Strategic, high-quality investments were made, adding attractive operations and establishing a foundation for expansion in the Southeast.
• Delivered strong same-store results and continued operational execution in the senior living business.

Negatives

• Cash balance decreased from $24.246 million at December 31, 2024, to $17.024 million at December 31, 2025.
• Net cash used in investing activities significantly increased from $(70.684) million in 2024 to $(227.971) million in 2025, indicating substantial capital deployment.
• Long-term debt increased from $0 at December 31, 2024, to $168.837 million at December 31, 2025.
• Interest expense, net, increased significantly in the fourth quarter from $(650) thousand in 2024 to $(3,253) thousand in 2025.

Risks

• Reduced prices and reimbursement rates for services could negatively impact financial performance.
• Challenges in the ability to acquire, develop, manage, or improve operations effectively.
• Difficulty in managing increasing borrowing costs as additional indebtedness is incurred to fund acquisitions and development.
• Potential inability to access capital on a cost-effective basis to continue implementing the growth strategy.
• Operating margins and profitability could suffer if the company is unable to grow and manage its increasing number of operations effectively.
• Competition from other companies in the acquisition, development, and operation of facilities poses a threat.
• Exposure to claims and lawsuits, including professional liability claims alleging personal injury, and other regulatory-related claims.
• The application of existing or proposed government regulations, or the adoption of new laws and regulations, could limit business operations, require significant expenditures, or restrict the ability to relocate operations.

Future Outlook

Management anticipates total revenue for 2026 to be between $1,133.6 million and $1,171.8 million, with adjusted diluted earnings per share projected between $1.26 and $1.36. Full year 2026 adjusted EBITDA is expected to range from $88.5 million to $94.1 million. This guidance includes costs related to the transition services agreement with UnitedHealth and Amedisys, reimbursement rate adjustments, and no unannounced acquisitions, reflecting management's expectations based on 2025 performance and current operating conditions.

Management Comments

• "2025 was a year of record-breaking performance and growth for Pennant. Our operational flywheel continues to gain momentum, even in the midst of accelerative expansion. Our growth wasn't only significant in its magnitude—it was strategic, high-quality investment. We added attractive operations to our footprint and created a foundation for additional expansion in the Southeast. At the same time, we drove strong same-store results and continued to execute in our senior living business." Brent Guerisoli, CEO.
• "We will be focused on integrating our new operations and continuing to instill operational excellence across our businesses in 2026. We have completed many acquisitions in our history, and we understand the importance of successful transitions, in terms of employee experience, culture, clinical excellence, and financial results. We saw tremendous momentum across virtually all key growth metrics in 2025, including growth in home health admissions of 44.1% and hospice average daily census of 28.6%, leading to revenue growth of 41.0% and segment Adjusted EBITDA growth of 37.8% year over year. Senior living year-over-year occupancy grew 90 basis points coupled with rate increases of 8.0%, generating revenue growth of 22.3% and Adjusted EBITDA improvement of 34.4%, year over year. Even as we worked diligently to transition many new operations, we delivered record operational and clinical performance in both segments. With seasoned leaders and well-performing operations anchoring our efforts, we are poised to continue this success throughout 2026." John Gochnour, COO.
• "We believe providing updated annual adjusted consolidated EBITDA guidance in addition to updated annual revenue and adjusted earnings per share guidance is helpful to understanding our expectations for our business and operational cash flow. This updated guidance reflects management's expectations based on 2025 performance and current operating conditions as well as the impacts of the transaction with UnitedHealth and Amedisys." Lynette Walbom, CFO.

Industry Context

StockSavvy.ai notes that Pennant Group's strong growth in home health, hospice, and senior living services aligns with broader demographic trends of an aging population and increasing demand for in-home and specialized elder care. The strategic expansion into the Southeast suggests a focus on high-growth regional markets, a common strategy among healthcare providers seeking to capitalize on favorable demographic shifts and fragmented local markets. The company's ability to achieve significant growth while integrating new operations positions it well within a competitive and evolving healthcare landscape.

Related Party Transactions

• An affiliate of the Company held its memory care units in transition and is converting the facility into an assisted living community.
• Costs were incurred as a result of a Transition Services Agreement between the Company and UnitedHealth, with fees totaling $3,001 for the year ended December 31, 2025.

Stakeholder Impact

• Shareholders: Positive impact due to strong financial performance, significant revenue and earnings growth, and positive 2026 guidance, potentially leading to increased share value.
• Employees: Management's focus on 'successful transitions, in terms of employee experience, culture, clinical excellence' suggests consideration for employee well-being during the integration of new operations.
• Customers (Patients/Residents): Continued emphasis on 'clinical excellence' and 'operational excellence' indicates a commitment to high-quality care.
• Creditors: Increased long-term debt ($168.837 million) and higher interest expense indicate increased leverage, which creditors will monitor, though strong operational cash flow could mitigate concerns.

Next Steps

• A live webcast and conference call will be held on February 26, 2026, to discuss the fourth quarter 2025 financial results.
• The company's Form 10-K for the year ended December 31, 2025, will be filed with the SEC.
• Management will focus on integrating new operations and continuing to instill operational excellence across businesses in 2026.
• The company aims to continue its success throughout 2026, building on the momentum from 2025.

Key Dates

Recommendation

The company delivered record-breaking performance in 2025 with substantial growth in revenue, net income, and key operational metrics across both home health/hospice and senior living segments. The 2026 guidance projects continued strong growth, indicating sustained momentum. While debt has increased, the underlying business expansion and profitability suggest effective capital deployment. The strategic acquisitions and focus on operational excellence position the company for continued market leadership in a growing sector.

Keywords

Home Health, Hospice, Senior Living, Healthcare Services, Earnings, Financial Results, Revenue Growth, Adjusted EBITDA, Occupancy, Admissions, PNTG, Pennant Group